{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:37:24Z","timestamp":1762673844713},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jbspin.2011.05.001","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T18:10:40Z","timestamp":1309198240000},"page":"389-392","source":"Crossref","is-referenced-by-count":8,"title":["Monitoring of bone turnover markers does not improve persistence with ibandronate treatment"],"prefix":"10.1016","volume":"79","author":[{"given":"Christian","family":"Roux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Rouanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Perrodeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2011.05.001_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","article-title":"Early discontinuation of treatment for osteoporosis","volume":"115","author":"Tosteson","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","article-title":"The impact of compliance with osteoporosis therapy on fracture rates in actual practice","volume":"15","author":"Caro","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"Cramer","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","article-title":"Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis","volume":"21","author":"Cramer","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00198-009-0930-1","article-title":"Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis","volume":"21","author":"Cott\u00e9","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1359\/jbmr.080510","article-title":"Fracture outcomes related to persistence and compliance with oral bisphosphonates","volume":"23","author":"Gallagher","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-007-0466-1","article-title":"Loss of treatment benefit due to low compliance with bisphosphonate therapy","volume":"19","author":"Penning-van Beest","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1359\/jbmr.060715","article-title":"Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study","volume":"21","author":"Adami","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0045","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-007-0506-x","article-title":"Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women","volume":"19","author":"Rabenda","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00198-008-0698-8","article-title":"Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience","volume":"20","author":"Briot","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0060","doi-asserted-by":"crossref","first-page":"b2266","DOI":"10.1136\/bmj.b2266","article-title":"Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data","volume":"338","author":"Bell","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","article-title":"Effect of monitoring bone turnover markers on persistence with risedronate treatment of post menopausal osteoporosis","volume":"92","author":"Delmas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0070","series-title":"Design and analysis of cluster randomisation trials","author":"Donner","year":"2000"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0075","doi-asserted-by":"crossref","unstructured":"Giraudeau B, P Ravaud P. Preventing bias in cluster randomised trials. PLoS Med 2009;6(5):e 1000065.","DOI":"10.1371\/journal.pmed.1000065"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0080","first-page":"899","article-title":"The statistical analysis of multiple binary measurements","volume":"41","author":"Donner","year":"1988","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0085","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/sim.2260","article-title":"Model mis-specification and overestimation of the intraclass correlation coefficient in cluster randomized trials","volume":"25","author":"Giraudeau","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.0006-341X.2004.00232.x","article-title":"Confidence interval estimation of the intraclass correlation coefficient for binary outcome data","volume":"60","author":"Zou","year":"2004","journal-title":"Biometrics"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","article-title":"The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial","volume":"89","author":"Clowes","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0105","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00198-006-0073-6","article-title":"Determinants of adherence to osteoporosis treatment in clinical practice","volume":"17","author":"Rossini","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2307\/2094540","article-title":"The Hawthorne experiments: first statistical interpretation","volume":"43","author":"Franke","year":"1978","journal-title":"Am Sociol Rev"},{"key":"10.1016\/j.jbspin.2011.05.001_bib0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","article-title":"Are randomized clinical trials good for us? Evidence for a \u201ctrial effect\u201d","volume":"54","author":"Braunholts","year":"2001","journal-title":"J Clin Epidemiol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T08:06:24Z","timestamp":1560326784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X11001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1297319X11001229"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2011.05.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}